The champagne was probably cold. The press release was warm. But for anyone who actually did the math on Capital B's latest €21 million raise, the buzz should've been a headache, not a high.
Over the past 48 hours, the European bitcoin treasury company confirmed it's issuing 36.2 million new shares at €0.58 per unit to snap up roughly 270 BTC. The company's treasury—already sitting at a respectable 3,145 BTC—is set to climb to 3,415 BTC. Headlines will scream "accumulation." Retail will nod approvingly. But here's the part that doesn't make the cover slide: each new share ships with four attached warrants, and if all of them get exercised, the BTC-per-share metric that actually matters for shareholders gets clobbered by 24.1%.
Let me say that again, slower. A 24.1% drop in your bitcoin exposure per share, not over five years—from the moment those warrants are in the money.
This isn't a story about a company buying bitcoin. It's a story about how a company is paying for it—and the structural trap that's been set for every existing holder in the process.
I've spent the last 36 hours pulling apart the placement memo, cross-referencing the warrant schedules, and stress-testing the dilution scenarios because, in a sideways market like this one, these are the deals that either make you a hero or break your portfolio. This one leans heavily toward the latter.
The TL;DR Verdict: This raise is a masterclass in narrative arbitrage. The company is selling you "growth" while the actual math delivers "erosion." It's a classic buy-the-hype, calculate-the-realities moment.
The Context: A Mini-MSTR Playbook With a European Twist
Let's back up. Capital B is not a protocol. It's not a DeFi project. It's a bitcoin treasury company—a publicly-listed vehicle designed to hold bitcoin on its balance sheet as its primary corporate strategy.
The playbook is straight out of Michael Saylor's manual. MicroStrategy (MSTR) proved the concept between 2020 and 2024: issue equity or debt, buy bitcoin, watch the share price track the underlying asset with a premium attached. Rinse and repeat. It's a model that doesn't require innovation—just conviction and relentless capital access.
But here's where the European version diverges from the American original. MSTR leans heavily on convertible notes—debt instruments that don't dilute shareholders until conversion, and even then, often at a premium to the current stock price. Capital B has chosen a different path: a private placement of shares with a strip of warrants attached.
Warrants are derivative instruments. They give the holder the right—but not the obligation—to buy more shares at a fixed price in the future. Unlike options, warrants are issued by the company itself. When they're exercised, the company prints brand new shares. Existing holders get their slice of the pie shrunk.
And that's exactly what Capital B has just done. The company is selling 36.2 million shares at €0.58 each. For every share, buyers get 4 warrants. The warrant exercise prices are staggered at €0.75, €0.98, and €1.27. They're valid for five years.
In the short term, this is "just a private placement." In the medium term, it's a slow-release dilution mechanism that's already baked into the company's capital structure.
The Core: Crunching the Real Numbers
Let me walk you through the technical breakdown because this is where the story gets genuinely uncomfortable for existing shareholders.
The Current State: Before this raise, Capital B held 3,145 BTC. The exact share count isn't fully disclosed in the reporting I've seen, but based on the BTC per million shares figure of 7.4725, we can reverse-engineer the approximate share base. The company is trading at roughly 419 million shares outstanding.
The Immediate Impact (Spot): The placement adds 36.2 million shares. That's roughly an 8.6% increase in the share count. The company gets €21 million to buy ~270 BTC. The treasury goes from 3,145 to 3,415 BTC.
Do the division math on the BTC-per-share ratio: it goes from 7.4725 to 7.4711 BTC per million shares. That's a drop of 0.02%. Essentially flat.
The company will spin this as "neutral to accretive." And on the surface, it is. You buy bitcoin, you issue shares, the ratio stays roughly matched. A 1% shareholder stays a 0.9% shareholder post-placement. Not great, but not catastrophic.
The Warrants (The Bomb): Here's where things get ugly. There are 144.9 million warrants in this deal alone—four for every new share issued. If every warrant gets exercised, that's an additional 144.9 million shares hitting the market.
Add those to the 419.6 million existing shares plus the 36.2 million placement shares, and you get a fully diluted share count of roughly 600 million shares.
The Fully Diluted Reality: 3,415 BTC divided by 600 million shares. The BTC per million shares metric drops to 5.6730. That's a 24.1% decline from the pre-raise level of 7.4725.
For context, a 1% shareholder pre-raise would see their stake shrink to 0.72% after the placement, and then further down to 0.65% or 0.55% depending on which warrants get exercised at what price levels.
Now, let's be fair. Warrants don't get exercised unless the stock price rises above the strike price. The warrants are priced at €0.75, €0.98, and €1.27—a 29% to 119% premium to the current placement price of €0.58. If the shares don't appreciate, the warrants expire worthless.
The problem? In a bitcoin bull market, those strikes are very likely to get hit. The whole thesis of this company is that bitcoin goes up. If that thesis plays out, the share price will likely follow, the warrants will be deep in the money, and the dilution becomes real.
The company has essentially created a scenario where the success of its own strategy guarantees the erosion of existing shareholder value.
The Contrarian Angle: A Feature, Not a Bug
Here's the take that nobody's talking about.
Warrants aren't just a funding mechanism. They're a marketing tool. They're a way to make a deal look attractive to new investors without needing the stock price to immediately jump.
When you're a small-cap European bitcoin treasury company competing against the likes of MSTR and Tokyo-listed Metaplanet, you don't have the luxury of issuing convertible notes at 0% interest. The market doesn't know you well enough. Your liquidity is too thin.
So you sweeten the pot. You sell shares at a discount to the market price and attach warrants that give buyers a free option on future upside. The new investors feel like they're getting a deal. The company gets its bitcoin. Everyone's happy.
Except for the existing shareholders. They just got handed the bill.
The company's own disclosure says the warrant dilution could lead to a 24.1% reduction in BTC per share. But here's the part that really gets my blood boiling: that calculation excludes other outstanding dilution tools.
The company didn't include the older BSA series warrants in its dilution math. It didn't include the convertible bond-linked warrants. It didn't include the 300 million euros of unissued TOBAM program capacity. The 24.1% number isn't the worst-case scenario. It's just the worst-case scenario the company is willing to admit to.
The real fully-diluted BTC-per-share figure could be significantly lower than 5.6730. I'd estimate it could be below 5.0 if all instruments get exercised.
And this is where I have to call out the governance issue. The shareholders have already authorized the board to raise up to €5 billion in capital and access a €100 billion credit facility. That's an enormous blank check. The management team has the keys to a capital machine that could print an almost unlimited number of shares.
The "growth" narrative is really a story about leverage. It's about borrowing against the future to buy an asset that's currently in a bull market. This works beautifully in a bull market. It's a total disaster in a bear market.
Let me paint that picture for you.
Bear Market Scenario: Bitcoin drops 50%. The treasury loses value. The stock price follows. The warrants become deeply out-of-the-money, so they expire worthless—but the damage is already done because the company already used the placement cash to buy bitcoin at the top. Now you have a company with a shrinking treasury, a falling share price, and no ability to raise more money. The "buy-raise-dilute" cycle grinds to a halt, and the stock enters a death spiral as shareholders flee.
Bull Market Scenario: Bitcoin doubles. The treasury pumps. The stock price follows. But now the warrants are in-the-money, and holders exercise them. The company gets more cash, which it uses to buy more bitcoin. The cycle continues. The only question is whether the bitcoin gains outpace the dilution. In this case, bitcoin needs to appreciate more than 24.1% just to keep existing shareholders whole on a per-share basis.
The math is brutally simple: If bitcoin doesn't outperform the dilution rate, you're losing exposure every single time the company raises money.
The Takeaway: Watch the Ratio, Not the Headlines
This deal is a perfect case study for why the "bitcoin treasury company" narrative needs to stop being evaluated by total BTC holdings. The only metric that matters is BTC per share. Total holdings are vanity. Per-share exposure is sanity.
I've been tracking this sector since MSTR first announced its bitcoin strategy. I've watched Metaplanet and Boyaa Interactive enter the space. And I can tell you this: the market has a dangerously short memory. It loves the accumulation headlines and completely ignores the dilution math until it's too late.
So here's my forward-looking advice, and I mean this for anyone holding bitcoin treasury stocks, not just Capital B. Every time one of these companies announces a raise, don't ask "how much bitcoin are they buying?" Ask "how many shares are they issuing to buy it?" Ask "what does the fully-diluted BTC-per-share ratio look like after this deal?" If the answer is "lower," you're getting played.
As for Capital B specifically—the immediate placement is a wash. The warrants are the ticking clock. I'll be watching the next few quarters with intense interest. If the stock price trades above the €0.75 warrant strike for a sustained period, expect the exercise announcements to follow. And if bitcoin enters a correction before those warrants get exercised, we might see the first major test of the "bitcoin treasury" thesis since the 2022 bear market.
The merge wasn't the end of the story for Ethereum, and this raise isn't the end of the story for Capital B. But it's a critical chapter.
Hackers don't hack, they listen. And right now, the smartest move is listening to what the warrant schedule is telling you about the future.
The real question isn't whether Capital B will buy more bitcoin. It's whether you're prepared for the structural dilution that comes bundled with every single share.
Stay sharp. Do the math. And don't trust the headline numbers when the footnotes tell a completely different story.